← FDA Drug Approvals (Drugs@FDA)

VEVYE

NDA · New Drug Application · Sponsor: HARROW EYE · Approved 2023-05-30

Drug application

FDA Application #

NDA217469

Application type

New Drug Application

Brand name

VEVYE

Generic name

CYCLOSPORINE OPHTHALMIC SOLUTION

Active ingredients

CYCLOSPORINE

Dosage form

SOLUTION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

HARROW EYE

Manufacturer

Harrow Eye, LLC

First approval

2023-05-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown